Publication Name	World Journal of Diabetes
Manuscript ID	95042
Country	United Kingdom

Received	2024-03-30 19:59
Peer-Review Started	2024-03-30 19:59
To Make the First Decision
Return for Revision	2024-05-02 20:03
Revised	2024-05-04 21:44
Second Decision	2024-05-20 02:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-05-20 07:26
Articles in Press	2024-05-20 07:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-28 17:28
Publish the Manuscript Online	2024-07-26 06:56

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Diabetic cardiomyopathy: Emerging therapeutic options
Manuscript Source	Invited Manuscript
All Author List	Cornelius James Fernandez, Sahana Shetty and Joseph M Pappachan
ORCID	Author(s) ORCID Number Cornelius James Fernandez http://orcid.org/0000-0002-1171-5525 Sahana Shetty http://orcid.org/0000-0003-0851-0411 Joseph M Pappachan http://orcid.org/0000-0003-0886-5255
Funding Agency and Grant Number
Corresponding Author	Sahana Shetty, MD, Professor, Senior Researcher, Department of Endocrinology, Kasturba Medical College, Manipal Academy of Higher Education, Madhav Nagar, Manipal 576104, Karnataka, India. sahana.shetty@manipal.edu
Key Words	Diabetic cardiomyopathy; Diabetic cardiomyopathy; Heart failure; Pathobiology; Teneligliptin
Core Tip	Diabetic cardiomyopathy (DbCM) is a common and underrecognized complication of diabetes mellitus. The pathobiological mechanisms of DbCM are not fully elusive and the therapeutic options are not adequate. Stages of DbCM include diastolic dysfunction followed by heart failure (HF) with preserved ejection fraction, systolic dysfunction and HF with reduced ejection fraction in its order of progression. Zhang et al, in a recent issue of the World Journal of Diabetes, demonstrate the potential pathophysiological changes of DbcM and explore the therapeutic potential of teneligliptin in mouse models of DbCM. Such experimental models might harness better research efforts to find an appropriate therapeutic strategy for DbCM in the near future.
Publish Date	2024-07-26 06:56
Citation	<p>Fernandez CJ, Shetty S, Pappachan JM. Diabetic cardiomyopathy: Emerging therapeutic options. <i>World J Diabetes</i> 2024; 15(8): 1677-1682</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i8/1677.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i8.1677

Full Article (PDF)	WJD-15-1677-with-cover.pdf
Manuscript File	95042_Auto_Edited-YJP.docx
Answering Reviewers	95042-answering-reviewers.pdf
Audio Core Tip	95042-audio.m4a
Conflict-of-Interest Disclosure Form	95042-conflict-of-interest-statement.pdf
Copyright License Agreement	95042-copyright-assignment.pdf
Peer-review Report	95042-peer-reviews.pdf
Scientific Misconduct Check	95042-scientific-misconduct-check.png
Scientific Editor Work List	95042-scientific-editor-work-list.pdf
CrossCheck Report	95042-crosscheck-report.pdf